Home / Products / Formulations / Svizera Healthcare /Manav Care / Flucofit Tab.


        Each tablet of FLUCOFIT contains;
        Fluconazole……150 mg
        Therapeutic Indications & Usage
        Recurrent vulvovaginal candidiasis
  • Hypersensitivity to fluconazole or any ingredient in the formulations.
  • Concomitant use with drugs that are known to prolong the QT interval and are metabolized by CYP3A4 (e.g., astemizole, cisapride, pimozide, quinidine).
        Precaution & Warnings
        Adverse Reactions
        GI effects (nausea, vomiting, abdominal pain, diarrhea), rash, transient increases in liver enzymes and bilirubin
        Drug interaction
        Drugs Metabolized by Hepatic Microsomal Enzymes
        Fluconazole is a potent inhibitor of CYP2C9 and a moderate inhibitor of CYP3A4.1 Because fluconazole has a long half-life, the enzyme-inhibiting effects of the drug persist for 4–5 days following discontinuance.1 Concomitant use of fluconazole and drugs metabolized by CYP2C9 or 3A4 may result in increased plasma concentrations of the concomitant drug; use caution and monitor closely.1
        Drugs that Prolong the QT Interval
        Concomitant use of fluconazole with drugs known to prolong the QT interval and that are metabolized by CYP3A4 is contraindicated
        Recommended Dosage & Administration
        Oral 150 mg FLUCOFIT given for 3 doses to achieve mycologic remission, then maintenance regimen of 150 mg once weekly for 6 months to prevent recurrence.
        FLUCOFIT TAB. – Three separate strips of fluconazole 150mg in a single pack


"Maneesh" Pharmaceuticals   |  Manufacturing Excellence  |   International Presence  |  Products
"Maneesh" for Doctors  |  Our Team  |  For the Patients  
Contact Us  |  Feedback  |  Site Map  | Search Maneesh